Browsing by Author "Patel, Derek"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemImplementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease(2018) Tyler, Christopher J.; Perez-Jeldres, Tamara; Ehinger, Erik; Capaldo, Brian; Karuppuchamy, Thangaraj; Boyer, Joshua D.; Patel, Derek; Dulai, Parambir; Boland, Brigid S.; Lannigan, Joanne; Eckmann, Lars; Ernst, Peter B.; Sandborn, William J.; Ho, Samuel B.; Rivera-Nieves, JesusBackground: Novel therapeutics for inflammatory bowel disease (IBD) are under development, yet mechanistic readouts at the tissue level are lacking. Techniques to assess intestinal immune composition could represent a valuable tool for mechanism of action (MOA) studies of novel drugs. Mass cytometry enables analysis of intestinal inflammatory cell infiltrate and corresponding molecular fingerprints with unprecedented resolution. Here, we aimed to optimize the methodology for isolation and cryopreservation of cells from intestinal tissue to allow for the potential implementation of mass cytometry in MOA studies.
- ItemInherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design(2020) Tyler, Christopher J.; Guzman, Mauricio; Lundborg, Luke R.; Yeasmin, Shaila; Perez-Jeldres, Tamara; Yarur, Andres; Behm, Brian; Dulai, Parambir S.; Patel, Derek; Bamias, Giorgos; Rivera-Nieves, JesusBackground and Aims: Intestinal biopsy sampling during IBD trials represents a valuable adjunct strategy for understanding drug responses at the tissue level. Given the length and distinctive embryonic origins of the proximal and distal colon, we investigated whether inherent regional differences of immune cell composition could introduce confounders when sampling different disease stages, or pre/post drug administration. Here, we capitalise on novel mass cytometry technology to perform deep immunophenotyping of distinct healthy colonic segments, using the limited numbers of biopsies that can be harvested from patients.